Similar articles

• Digoxin in the management of cardiovascular disorders.

  Gheorghiade M, Adams KF Jr, Colucci WS. Gheorghiade M, et al. Circulation. 2004 Jun 22;109(24):2959-64. doi: 10.1161/01.CIR.0000132482.95686.87. Circulation. 2004. PMID: 15210613 Review. No abstract available.
• Myocardial Na,K-ATPase and digoxin therapy in human heart failure.

  Kjeldsen K, Bundgaard H. Kjeldsen K, et al. Ann N Y Acad Sci. 2003 Apr;986:702-7. doi: 10.1111/j.1749-6632.2003.tb07285.x. Ann N Y Acad Sci. 2003. PMID: 12763921 Review.
• Effects of chronic digoxin treatment on cardiac function, electrolytes, and sarcolemmal ATPase in the canine failing heart due to chronic mitral regurgitation.

  Prasad K, O'Neil CL, Bharadwaj B. Prasad K, et al. Am Heart J. 1984 Dec;108(6):1487-94. doi: 10.1016/0002-8703(84)90696-3. Am Heart J. 1984. PMID: 6095632
• The action of digoxin and digoxigenin-monodigitoxoside on the sodium pump and on the contractility in isolated guinea-pig atria.

  Godfraind T, Ghysel-Burton J. Godfraind T, et al. Arch Int Pharmacodyn Ther. 1978 Aug;234(2):340-1. Arch Int Pharmacodyn Ther. 1978. PMID: 213038 No abstract available.
• Digoxin in heart failure.

  Spencer AP. Spencer AP. Crit Care Nurs Clin North Am. 2003 Dec;15(4):447-52. doi: 10.1016/s0899-5885(02)00091-6. Crit Care Nurs Clin North Am. 2003. PMID: 14717389 Review.